Less medication switching after initial start with atypical antipsychotics

被引:11
作者
Hugenholtz, GWK
Heerdink, ER
Nolen, WA
Egberts, ACG
机构
[1] Utrecht Inst Pharmaceut Sci, Dept Pharmacoepidemiol & Pharmacotherapy, NL-3508 TB Utrecht, Netherlands
[2] Altrecht Inst Mental Hlth Care, Utrecht, Netherlands
[3] Univ Utrecht, Med Ctr, Dept Psychiat, Utrecht, Netherlands
关键词
antipsychotic; switch; epidemiology; pharmacoepidemiology;
D O I
10.1016/S0924-977X(03)00043-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We investigated the extent and time of switching to another oral antipsychotic in newly admitted in-patients that started oral antipsychotic therapy. In a retrospective follow-up study of 522 newly admitted patients who started with an oral antipsychotic, we applied a case-control analysis considering patients switching to another oral antipsychotics as cases. Association between patient characteristics and switching antipsychotic medication was evaluated using logistic regression analysis. A Kaplan-Meier plot was performed to analyse time to switch. Patients initially treated with an oral typical antipsychotic showed a twofold increased risk to switch to another antipsychotic compared to patients treated with an oral atypical antipsychotic (adjusted OR = 1.79 95% CI = 1.15-2.78). The Kaplan-Meier survival analysis revealed that patients started with a typical antipsychotic switched sooner compared to patients on atypical antipsychotics. Atypical antipsychotics are less frequently associated with switching in comparison with typical antipsychotics suggesting overall better treatment satisfaction. (C) 2003 Elsevier B.V./ECNP. All rights reserved.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 25 条
[1]  
[Anonymous], 2000, ANATOMICAL THERAPEUT
[2]  
[Anonymous], 1994, DIAGNOSTIC STAT MANU
[3]  
DAVIS JM, 1992, PSYCHOPHARMACOL BULL, V28, P151
[4]  
DUGGAN L, 2003, OLANZAPINE SCHIZOPHR
[5]   Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis [J].
Geddes, J ;
Freemantle, N ;
Harrison, P ;
Bebbington, P .
BRITISH MEDICAL JOURNAL, 2000, 321 (7273) :1371-1376
[6]   PHARMACO-MORBIDITY LINKAGE - A FEASIBILITY STUDY COMPARING MORBIDITY IN 2 PHARMACY BASED EXPOSURE COHORTS [J].
HERINGS, RMC ;
BAKKER, A ;
STRICKER, BHC ;
NAP, G .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1992, 46 (02) :136-140
[7]  
Herz MI, 1997, AM J PSYCHIAT, V154, P1
[8]  
HUGENHOLTZ GWK, 2002, PHARM WEEKBLAD, V137, P738
[9]  
KENNEDY E, 2003, COCHRANE LIB
[10]   Mechanisms of action of atypical antipsychotic drugs: A critical analysis [J].
Kinon, BJ ;
Lieberman, JA .
PSYCHOPHARMACOLOGY, 1996, 124 (1-2) :2-34